These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 24378323)

  • 21. Diagnosis of cardiac sarcoidosis despite negative findings on serial late gadolinium enhancement with cardiac magnetic resonance imaging/
    Tanaka TD; Nagai T; Nagoshi T; Yoshimura M
    J Nucl Cardiol; 2020 Dec; 27(6):2149-2153. PubMed ID: 31773564
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic accuracy of dynamic gadoxetic-acid-enhanced MRI and PET/CT compared in patients with liver metastases from neuroendocrine neoplasms.
    Armbruster M; Zech CJ; Sourbron S; Ceelen F; Auernhammer CJ; Rist C; Haug A; Singnurkar A; Reiser MF; Sommer WH
    J Magn Reson Imaging; 2014 Aug; 40(2):457-66. PubMed ID: 24347148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative Analysis of Myocardial Viability Multimodality Imaging in Patients with Previous Myocardial Infarction and Symptomatic Heart Failure.
    Kazakauskaite E; Vajauskas D; Unikaite R; Jonauskiene I; Virbickiene A; Zaliaduonyte D; Lapinskas T; Jurkevicius R
    Medicina (Kaunas); 2022 Mar; 58(3):. PubMed ID: 35334543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 18F-FDG PET-Based Imaging of Myocardial Inflammation Predicts a Functional Outcome Following Transplantation of mESC-Derived Cardiac Induced Cells in a Mouse Model of Myocardial Infarction.
    Vasudevan P; Gaebel R; Doering P; Mueller P; Lemcke H; Stenzel J; Lindner T; Kurth J; Steinhoff G; Vollmar B; Krause BJ; Ince H; David R; Lang CI
    Cells; 2019 Dec; 8(12):. PubMed ID: 31835854
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systematically evaluating DOTATATE and FDG as PET immuno-imaging tracers of cardiovascular inflammation.
    Toner YC; Ghotbi AA; Naidu S; Sakurai K; van Leent MMT; Jordan S; Ordikhani F; Amadori L; Sofias AM; Fisher EL; Maier A; Sullivan N; Munitz J; Senders ML; Mason C; Reiner T; Soultanidis G; Tarkin JM; Rudd JHF; Giannarelli C; Ochando J; Pérez-Medina C; Kjaer A; Mulder WJM; Fayad ZA; Calcagno C
    Sci Rep; 2022 Apr; 12(1):6185. PubMed ID: 35418569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Imaging of the myocardium using (18)F-FDG-PET/MRI.
    Ferda J; Hromádka M; Baxa J
    Eur J Radiol; 2016 Oct; 85(10):1900-1908. PubMed ID: 27470994
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical Utility of Combined FDG-PET/MR to Assess Myocardial Disease.
    Abgral R; Dweck MR; Trivieri MG; Robson PM; Karakatsanis N; Mani V; Padilla M; Miller M; Lala A; Sanz J; Narula J; Fuster V; Contreras J; Kovacic JC; Fayad ZA
    JACC Cardiovasc Imaging; 2017 May; 10(5):594-597. PubMed ID: 27372018
    [No Abstract]   [Full Text] [Related]  

  • 28. Magnetic resonance imaging (MRI) for the assessment of myocardial viability: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(15):1-45. PubMed ID: 23074392
    [TBL] [Abstract][Full Text] [Related]  

  • 29. (18)F-Fluorodeoxyglucose PET/MR Imaging in Head and Neck Cancer.
    Platzek I
    PET Clin; 2016 Oct; 11(4):375-86. PubMed ID: 27593244
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimization of the reference region method for dual pharmacokinetic modeling using Gd-DTPA/MRI and (18) F-FDG/PET.
    Poulin É; Lebel R; Croteau É; Blanchette M; Tremblay L; Lecomte R; Bentourkia M; Lepage M
    Magn Reson Med; 2015 Feb; 73(2):740-8. PubMed ID: 24604379
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential influence of Gadolinium contrast on image segmentation in MR-based attenuation correction with Dixon sequences in whole-body 18F-FDG PET/MR.
    Ruhlmann V; Heusch P; Kühl H; Beiderwellen K; Antoch G; Forsting M; Bockisch A; Buchbender C; Quick HH
    MAGMA; 2016 Apr; 29(2):301-8. PubMed ID: 26667965
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of cardiac magnetic resonance imaging and fluorodeoxyglucose positron emission tomography in the assessment of myocardial viability: meta-analysis and systematic review.
    Adhaduk M; Paudel B; Liu K; Ashwath M; Gebska MA; Delcour K; Samuelson RJ; Giudici M
    J Nucl Cardiol; 2023 Dec; 30(6):2514-2524. PubMed ID: 37758962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 18F-FDG-PET/CT better localizes active spinal infection than MRI for successful minimally invasive surgery.
    Nakahara M; Ito M; Hattori N; Magota K; Takahata M; Nagahama K; Sudo H; Kamishima T; Tamaki N; Iwasaki N
    Acta Radiol; 2015 Jul; 56(7):829-36. PubMed ID: 25080515
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined Cardiac Fluorodeoxyglucose-Positron Emission Tomography/Magnetic Resonance Imaging Assessment of Myocardial Injury in Patients Who Recently Recovered From COVID-19.
    Hanneman K; Houbois C; Schoffel A; Gustafson D; Iwanochko RM; Wintersperger BJ; Chan R; Fish JE; Howe KL; Thavendiranathan P
    JAMA Cardiol; 2022 Mar; 7(3):298-308. PubMed ID: 35019953
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    Vasudevan P; Gäbel R; Stenzel J; Förster J; Kurth J; Vollmar B; Krause BJ; Ince H; David R; Lang CI
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32397287
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ferumoxytol Does Not Impact Standardized Uptake Values on PET/MR Scans.
    Muehe AM; Yerneni K; Theruvath AJ; Thakor AS; Pribnow A; Avedian R; Steffner R; Rosenberg J; Hawk KE; Daldrup-Link HE
    Mol Imaging Biol; 2020 Jun; 22(3):722-729. PubMed ID: 31325083
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expanding the versatility of cardiac PET/CT: feasibility of delayed contrast enhancement CT for infarct detection in a porcine model.
    Holz A; Lautamäki R; Sasano T; Merrill J; Nekolla SG; Lardo AC; Bengel FM
    J Nucl Med; 2009 Feb; 50(2):259-65. PubMed ID: 19164240
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FDG PET/CT: normal variations and benign findings--translation to PET/MRI.
    Beheshti M; Kim CK
    PET Clin; 2014 Apr; 9(2):xiii-xiv. PubMed ID: 25030290
    [No Abstract]   [Full Text] [Related]  

  • 39. Hybrid imaging with PET/MRI: ready for clinical routine?
    Ferda J
    Eur J Radiol; 2017 Sep; 94():A1-A2. PubMed ID: 28551301
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PET/MRI of metabolic activity in osteoarthritis: A feasibility study.
    Kogan F; Fan AP; McWalter EJ; Oei EHG; Quon A; Gold GE
    J Magn Reson Imaging; 2017 Jun; 45(6):1736-1745. PubMed ID: 27796082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.